Skip to Main Content


Skip Nav Destination

Abstract CT105: First in human phase I trial of adenoviral vectors expressing Flt3L and HSV1-TK to treat newly diagnosed high-grade glioma by reprogramming the brain immune system

Cancer Res (2020) 80 (16_Supplement): CT105.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Sheridan L. Swan
  • Nalini Mehta
  • Ekaterina Ilich
  • Steven H. Shen
  • Daniel S. Wilkinson
  • Alexa R. Anderson
  • Tatiana Segura
  • Luis Sanchez-Perez
  • John H. Sampson
  • Ravi V. Bellamkonda
Frontiers in Immunology (2023) 14
Close Modal

or Create an Account

Close Modal
Close Modal